In this episode of The Interventional Glaucoma Podcast, host Dr. Cathy McCabe is joined by Dr. Mark Gallardo and Mr Dan Lindfield to explore ELIOS™, a minimally-invasive and precise solution for patients with cataracts and glaucoma. The conversation delves into patient selection criteria, effective communication strategies, and the need for a shift towards holistic patient-centered care.
The Interventional Glaucoma Podcast
Episode 5: ELIOS Explained: Pearls for Patient Selection
Key Takeaways
- The ELIOS Treatment: ELIOS is a precise and minimally invasive treatment option for glaucoma. The device uses excimer laser technology via a small probe to create microchannels in the trabecular meshwork, providing effective intraocular pressure reduction with minimal tissue damage.
- Integration of Glaucoma Treatment with Cataract Surgery: ELIOS can be integrated into cataract procedures, offering patients the benefits of simultaneous treatment for multiple ocular conditions and increasing patients’ quality of life by decreasing the burden of eye drops.
- Patient Selection Criteria for Elios: Identifying suitable candidates for ELIOS treatment involves considering factors such as disease severity, anatomy and co-morbidities. Patients with open-angle glaucoma and mild to moderate disease stand to benefit most from ELIOS, while careful evaluation is necessary to ensure optimal outcomes.
- Effective Patient Communication: Clear and informative communication with patients is essential in facilitating understanding and alleviating concerns regarding ELIOS treatment. Surgeons should emphasize the precision, safety, and long-term efficacy of ELIOS, providing reassurance to patients.
- The Future of ELIOS: The surgeons highlight the importance of raising awareness about innovative treatments such as ELIOS among patients and fellow ophthalmologists in order to ensure broader access and enhance patient care.
Guests
Dr. Cathleen McCabe
Dr. Cathleen McCabe serves as the Chief Medical Officer at Eye Health America and is a cataract and refractive specialist who regularly performs MIGS procedures. She is one of the foremost eye surgeons today, performs thousands of cataracts a year, and is an early adopter of new ophthalmic technologies that improve patient QOL. Dr. McCabe was recently honored for being on the Global Top 100 Power List for 2021 and 2022.
Dr. Mark Gallardo
Dr. Mark Gallardo is a cataract and glaucoma surgeon based in El Paso, Texas. He is a recognized expert in micro-invasive glaucoma surgery and is routinely invited to lecture at multiple major national and international ophthalmic conferences to share his knowledge. He is widely published in the peer-reviewed medical literature and is the principal investigator for multiple ongoing clinical trials in the fields of cataract and glaucoma surgery.
Mr Dan Lindfield
Mr Dan Lindfield is a consultant ophthalmologist and cataract surgeon in Guildford and Farnham who specialises in cataracts and glaucoma surgery, including laser therapies for glaucoma, such as SLT, trabeculectomy, and minimally-invasive glaucoma surgery (MIGS). He has an extensive portfolio of research and academic work which is published in leading peer-reviewed journals.
Additional Resources
Follow Dr. Cathleen McCabe on social:
Dr Cathleen McCabe | LinkedIn
Follow Dr. Mark Gallardo on social:
Dr Mark Gallardo | LinkedIn
Follow Mr Dan Lindfield on social:
Mr Dan Lindfield | LinkedIn
Episode 10: Glaucoma Management Five Years From Now
Dr. Karl Mercieca, Dr. Gok Ratnarajan, and Dr. Ana Miguel discuss the future of glaucoma management.
Episode 9: Physician experiences with ELIOS and the rationale for routinely combining MIGS with cataract surgery
Dr Jose Belda, Dr María Isabel Canut, and Dr Marta Ibarz discuss the rationale and benefits of routinely combining MIGS with cataract surgery.
Episode 8: TM-MIGS: Impact on patient quality of life
Professor Christophe Baudouin, Mr Gok Ratnarajan, and Dr Ana Miguel discuss the impact of glaucoma treatments on patients' quality of life.